The epidermal growth factor receptor (EGFR) plays a central role in CRC pathogenesis through activation of downstream <i>RAS</i>/<i>RAF</i>/MAPK and PI3K/AKT/mTOR signaling pathways, and has become a major therapeutic target. The gene discussed is AKT1; the disease is colorectal carcinoma.